Development of a Rapid In Vitro Screening Assay Using Metabolic Inhibitors to Detect Highly Selective Anticancer Agents
Main Authors: | Felagot A. Abebe, Megan D. Hopkins, Suraj N. Vodnala, Robert J. Sheaff, Angus A. Lamar |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2021-07-01
|
Series: | ACS Omega |
Online Access: | https://doi.org/10.1021/acsomega.1c02203 |
Similar Items
-
Anticancer drug screening: standardization of in vitro wound healing assay
by: Vitor M. Almeida, et al.
Published: (2020-03-01) -
Anticancer drug screening of natural products: In vitro cytotoxicity assays, techniques, and challenges
by: Agustina Setiawati, et al.
Published: (2022-01-01) -
1-Benzamido-1,4-dihydropyridine derivatives as anticancer agents: in vitro and in vivo assays
by: Sandra Ardevines, et al.
Published: (2023-02-01) -
Discovery of New Glucose Uptake Inhibitors as Potential Anticancer Agents by Non-Radioactive Cell-Based Assays
by: Hsueh-Chih Hung, et al.
Published: (2022-11-01) -
Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents
by: Ververis K, et al.
Published: (2013-02-01)